Pancreatic Cancer Research

ResearcherAffiliated Hospital of Guizhou Medical UniversityNo recent work listed

Peng Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4936-2064; OpenAlex author ID A5100785027. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2020: 1 paper · 2021: 2 papers

Papers 3

  1. [6]-Paradol suppresses proliferation and metastases of pancreatic cancer by decreasing EGFR and inactivating PI3K/AKT signaling. Co-author DOI 10.1186/s12935-021-02118-0↗
  2. Hypoxia-Induced ZWINT Mediates Pancreatic Cancer Proliferation by Interacting With p53/p21. Co-author DOI 10.3389/fcell.2021.682131↗
  3. Pegylated G-CSF Combined with mFOLFIRINOX for Advanced Pancreatic Cancer Patients. Co-author DOI 10.2169/internalmedicine.3790-19↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jie Wang · 2 shared papers, 2021 · strength 0.28
  2. Zhiwei He · 2 shared papers, 2021 · strength 0.28
  3. Xueyi Jiang · 2 shared papers, 2021 · strength 0.28
  4. Jian Xu · 2 shared papers, 2021 · strength 0.28
  5. Yankun Chen · 2 shared papers, 2021 · strength 0.28
  6. Xinyuan Liu · 2 shared papers, 2021 · strength 0.28
  7. Jianxin Jiang · 2 shared papers, 2021 · strength 0.28
  8. Benhong Zhou · 1 shared paper, 2020 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.